1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
NCMRR Early Career Research Award (R03 Clinical Trial Optional) is sponsored by National Institutes of Health (NIH) — National Center for Medical Rehabilitation Research (NCMRR). This program supports basic and clinical rehabilitation research, specifically targeting the pathophysiology, repair, and recovery of motor function for chronically injured nervous systems—including spinal cord injuries.
It funds rehabilitative strategies involving exercise, motor training, behavioral modifications, and assistive technologies to help investigators gather preliminary data for subsequent larger projects.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Nonprofits with or without 501(c)(3) IRS status (including community-based organizations), public/private higher education institutions, tribal governments, and small businesses. Eligible nationwide, including organizations located in Arizona. Confirm the full requirements in the official notice before applying.
The current listing shows standard NIH R03 award limits apply (typically up to $50,000–$100,000 per year in direct costs for up to 2 years). Verify award ceilings, matching requirements, and allowable costs in the official notice.
Applications for NCMRR Early Career Research Award (R03 Clinical Trial Optional) are due January 7, 2028. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
NCMRR Early Career Research Award (R03 Clinical Trial Optional) is funded by National Institutes of Health (NIH) — National Center for Medical Rehabilitation Research (NCMRR). Verify program details on the funder's official page before applying.
This opportunity targets applicants in Arizona. If your organization operates elsewhere, check the official notice for location requirements.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
AMSSM/ACSM Breaking Barriers Research Grant is sponsored by American Medical Society for Sports Medicine (AMSSM) Foundation and American College of Sports Medicine (ACSM). This grant supports innovative research focused on the health and well-being of traditionally underrepresented communities in sports medicine. The purpose is to foster research that can “break barriers” and grow the evidence base supporting historically underserved communities within sports medicine.
Transformative Capital Investment Grant Program (CAP) (Year 2) is sponsored by Kansas Department of Health and Environment (KDHE). The CAP grant makes funding available to help providers invest in transforming how they serve their communities. This could include investments in infrastructure or equipment that supports non-emergency medical transportation to improve rural health access. The program is part of the Kansas Rural Health Transformation Program, funded by the Centers for Medicare and Medicaid Services (CMS).
Alliance for Innovation on Maternal Health (AIM) Technical Assistance Center is sponsored by Health Resources and Services Administration (HRSA Maternal and Child Health Bureau). Provides comprehensive technical assistance to support states, territories, tribal communities, and birthing facilities participating in the AIM quality improvement initiative to make birth safer and improve maternal and child health outcomes.
The memorandum of agreement was signed August 4 and 5, disclosed by House appropriators on September 3, and runs through 2036. It names no dollar figure. Here is what is actually established, what is still speculation, and what researchers holding or planning NIAID biodefense awards should do before September 30.
Read articleRFA-EB-28-004, NextTech: Translational Development of Next-Generation Diagnostic and Therapeutic Devices (R18), puts about $6 million into 8 to 12 BRAIN and HEAL Initiative device-development awards. Budgets should rarely exceed $750,000 in direct costs a year, projects run up to three years, nine institutes participate, and there are six due dates from February 1, 2027 through February 1, 2030. Here is what the program requires and how to write a competitive application.
Read articleThe NIH Common Fund launched PRIMED-AI — Precision Medicine with AI: Integrating Imaging with Multimodal Data — as five coordinated funding opportunities (RFA-RM-27-011 through -015) that build a full pipeline from standards to clinic. Here is how the Playbook, Data-to-Model partnerships, Model-to-Clinic translation, Validation Center, and Logistics Center fit together, what each pays, who is eligible, and how to position before the October 2026 deadlines.
Read article